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from this study should emphasize the need for the inclussion of stratiﬁ-
cation by gender in future clinical trials. 
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Objective: To evaluate the expression and clinical signiﬁcance of cyto-
keratin subtypes (CK7,CK20) and thyroid transcription factor-1 (TTF-
1) in bronchioloalveolar carcinoma (BAC), furthermore, investigate the 
value of these factors in identiﬁcation of the prognosis of BAC.
Methods: 81 cases of surgically resected BAC specimens (including 
68 nonmucinous types and 13 mucinous types) were collected from 
The Cancer Hospital of Tianjin Medical University during the period 
from 1990 to 2000. Expression of CK7, CK20 and TTF-1 of them 
was studied by immunohistochemistry. The value of the three factors 
in identiﬁcation of the prognosis of BAC was examined by survival 
analysis. 
Results: No signiﬁcant correlation was found between CK7 positive 
rate and age-groups, clinical stages and pathological subtypes of BAC 
(P>0.05). The positive rate of CK20 was higher in stage I-II and muci-
nous types than that in stage III and nonmucinous types. The positive 
rate of TTF-1 was signiﬁcantly higher in stage III and nonmucinous 
types than that in stage I-II and mucinous types (P<0.05). There was 
a statistically signiﬁcant positive correlation between expression of 
CK7 and TTF-1 (r=0.257, P=0.021). The main prognostic factors were 
TTF-1 expression, clinical stage, tumor diameter and N stage (P<0.05). 
Strata analysis suggested that the survival time of BAC with TTF-1 
positive was superior to that with TTF-1negative in nonmucinous types 
(P=0.009); the survival time of BAC with TTF-1 positive was superior 
to that with TTF-1 negative in stage III (P=0.022). Cox Regression 
suggested that TTF-1 (P=0.035), TNM stage (P=0.000), tumor diameter 
(P=0.034), N stage (P=0.000) were independent factors affecting the 
prognosis. 
Conclusions: There is a statistically signiﬁcant positive correlation 
between expression of CK7 and TTF-1. TTF-1 and CK20 provide a 
new evidence for the molecular staging of BAC. TTF-1, TNM stage, 
tumor diameter and N stage are all independent factors affecting the 
prognosis of BAC.
P2-108 BSTB: Prognostic Factors Posters, Tue, Sept 4 
Prognostic significance of DAPK hypermethylation in patients with 
resected non-small cell lung cancer
Zemaitis, Marius1 Rieger, Norman2 Dienemann, Hendrik3 Manegold, 
Christian4 Fischer, Jurgen R.5 Sakalauskas, Raimundas1 Lahm, Harald2 
1 Clinic of Pulmonology and Immunology, Kaunas University of Medi-
cine, Kaunas, Lithuania 2 Immunology-Molecular Biology Laboratory, 
Thoraxklinik Heidelberg gGmbH, Heidelberg, Germany 3 Dept. of Sur-
gery, Thoraxklinik Heidelberg gGmbH, Heidelberg, Germany 4 Dept. 
of Medical Oncology, Thoraxklinik Heidelberg gGmbH, Heidelberg, 
Germany 5 Klinik Lowenstein gGmbH, Germany, Lowenstein, Germany 
Background: Surgical resection is the most effective treatment for 
early stage non-small cell lung cancer. However, even after curative 
resection, many patients develop recurrences. Although the adjuvant 
chemotherapy has recently become the standard of therapy for radi-
cally resected early stage NSCLC, the beneﬁt is modest. Developing 
of new molecular markers could more accurately predict the treatment 
outcome. 
Purpose: We examined whether hypermethylation of tumor suppres-
sor genes DAPK, p16INK4a, APC1A, p14ARF, E-cadherin, MGMT 
and RASSF1A could predict the clinical outcome of 31 patients with 
primary NSCLC after radical surgical resection.
Materials and Methods: The methylation status of candidate genes 
was analyzed by methylation-speciﬁc PCR. Genomic DNA was puri-
ﬁed from tumor tissue and was subsequently treated with sodium 
bisulﬁte to convert unmethylated cytosine bases to uracil. To increase 
the sensitivity we have developed a nested PCR approach. A ﬁrst PCR 
ampliﬁes a larger fragment using primers, which do not discriminate 
between the methylated or wild-type genotype. The second PCR uses 
nested primers, which speciﬁcally amplify either methylated or un-
methylated sequences. Results were visualized by gel electrophoresis. 
Results: Methylation was detected at a frequency of 74.2% for DAPK, 
77.4% for p16INK4a, 74.2% for APC1A, 71.0% for p14ARF, 80.0% 
for E-cadherin, 32.3% for MGMT and 61.3% for RASSF1A. The 
univariate Cox regression model showed that methylation status of 
DAPK, p16INK4a, APC1A, p14ARF, regional lymph node status and 
gender were signiﬁcant risk factors for recurrence of NSCLC (hazards 
ratios, DAPK methylated, 55.26 [95% CI, 1.03 to 2967.62; p=0.048], 
p16INK4a methylated, 4.68 [95% CI, 1.03 to 21.34; p=0.048]; APC1A 
methylated, 0.293 [95% CI, 0.10 to 0.83; p=0.021]; p14ARF methyl-
ated, 0.312 [95% CI, 0.12 to 0.83; p=0.020]; N2, 3.59 [95% CI, 1.24 to 
10.35; p=0.018]; and male, 4.25 [95% CI, 1.22 to 14.87; p=0.023]. The 
stepwise multivariate Cox regression model identiﬁed DAPK methyla-
tion status as the only independent risk factor for recurrence.
Conclusion: Our preliminary results suggest that hypermethylation of 
DAPK could be an important factor in predicting NSCLC recurrence 
but further investigations are needed.
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Background: Bone sialoprotein(BSP) and osteopontin(OPN) have 
been demonstrated predictive of bone metastasis in breast and prostate 
carcinoma, consistent with the proposed role of BSP as a stimulator 
of bone mineralization and OPN in differentiation and activation of 
osteoclasts. Bone metastasis(BM) is often developed in non-small-cell 
lung cancer(NSCLC), but no predictive biomarkers was identiﬁed for 
high risk of metastatic bone dissemination.
Methods: 180 completely resected NSCLC patients(of 38 patients 
subsequently developed BM) were included in the investigation. Paraf-
ﬁn embedded primary tissue of these 180 patients were supplied to 
produced a tissue microarray, and investigated by immunohistochem-
istry for BSP and OPN. Different expressions of these two biomarkers 
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among groups were estimated by χ2 test, bone metastasis-free survival 
was analyzed by Kaplan-Meier method. The prognostic impact of 
clinicopathologic parameters and biomarker expression was evaluated 
by Cox propotional hazards model.
Results: BSP expression was associated with BM(P=0.027), OPN 
expression could not reach statistical signiﬁcance(P=0.495). Survival 
analysis demonstrated that strong expression of BSP(P=0.036), N 
stage(P=0.000) and overall stage(P=0.001) were associated with time 
interval to BM. Multivariate analysis showed BSP expression(RR=1.7
79,P=0.012) and overall stage(RR=1.620,P=0.005) were independent 
prognostic factors for BM. 
Conclusions: BSP protein expression in the primary resected NSCLC 
is strongly associated with BM and could be used to identify high-risk 
patients, and further improve treatment of NSCLC. Correlation of OPN 
protein expression and bone metastasis need further investigation.
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Background: Lung cancer remains to be the leading cause of mortal-
ity for cancer deaths despite the availability of various chemo- and 
radiotherapeutic regimens. One of the limitations is due to resistance 
of cancers cells to apoptotic stimuli of various anti-neoplastic agents. 
Autophagic cell death has recently been shown to be increased in the 
irradiated apoptosis-incompetent cells.
Method: We tested whether inhibition of apoptosis and induction of 
autophagy can be utilized as an adjunctive to the radiation therapy, 
using cell culture and xenograft models of lung cancer. In order to test 
this hypothesis, we asked whether inhibitor of Caspase-3, Z-DEVD, 
and inducer of autophagy, RAD001, can enhance the cytotoxic effects 
of irradiation in human lung cancer cells, H460. 
Result: We found that combination of Z-DVED and RAD001 
markedly enhanced radiosensitization of H460 cells than individual 
treatment alone both in vitro as well as xenograft murine model. The 
enhanced radiosensitization was associated with upregulation of au-
tophagosome formatiom. Furthermore, when we addressed the speciﬁc 
cellular behavior associated with combination treatment, we observed 
defects in angiogenesis, inhibition of proliferation, as well as reduction 
in apoptosis. 
Conclusion: We demonstrate that radiation therapy, combined with 
inhibition of Caspase-3 and induction of autophagy, may be a novel 
therapeutic option for lung cancer patients. 
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The aim of this work was to study cytogenetic damages in vivo induced 
by single therapeutic irradiation in population of peripheral blood 
lymphocytes (PBL) of squamous cell lung cancer (SCLC) patients and 
to estimate the possibilities of using these date for prediction of tumour 
radiosensitivity. It becomes especially urgent in connection with accel-
eration of growth in the number of oncological cases in areas suffering 
from the Chernobyl accident. 
The estimation of lymphocytes with micronuclei and apoptosis in PBL 
of the patients was carried out before and after single therapeutic irra-
diation (4 Gy). The criterion of patient somatic cell radiosensitivity was 
the response of tumour tissue to radiotherapy. Depending on treatment 
result all patients were divided into radiosensitive and radioresistant 
groups. 
It was revealed that the levels of spontaneous mutational (0,32±0,10%) 
and cell-lethal (6,33±0,45%) processes in PBL in vivo in SCLC pa-
tients with clinically radiosensitive tumours were 1,5-2 fold as high as 
in the control (0,14±0,08% - cells with micronuclei; 4,13±0.67% - cells 
with apoptosis), and in patients with clinically radioresistant tumours 
didn’t differ from those in people without oncopathology. 
After single therapeutic irradiation signiﬁcant increase (1,5-2 fold) 
in the lymphocyte level with micronuclei and degenerative disorders 
was observed in patients with high tumour tissue radiosensitivity in 
comparison with the spontaneous level in the same patients, with the 
absence of essential changes being noted between the levels in patients 
with radioresistant tumour tissue. 
Thus, studying cytogenetic parameters of the mutational process and 
the cell-lethal effect in vivo in PBL of patients suffering from SCLC 
has established additional criteria for estimating and predicting radio-
sensitivity of somatic cells in SCLC patients for increasing radiothera-
phy efﬁciency.
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Background: Non-small cell lung cancer (NSCLC) cells are com-
monly progressed to radiation-resistant state, making it difﬁcult to treat 
by conventional radiotherapy. The aim of this study is to establish the 
